Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125848783> ?p ?o ?g. }
- W2125848783 endingPage "3022" @default.
- W2125848783 startingPage "3009" @default.
- W2125848783 abstract "Objective: The objectives of this article are to review the pathophysiology of type 2 diabetes mellitus (T2DM), present the rationale for a pathophysiologically based treatment approach for patients with T2DM and discuss the role of the therapeutic combination of pioglitazone and exenatide in the management of T2DM.Methods: References were identified from searches of the PubMed database that were conducted in May 2007, October 2007 and March 2008 and updates to product labeling that occurred between May 2007 and December 2007. Information was selected for inclusion on the basis of its relevance to the pathophysiology of T2DM or the clinical use of thiazolidinediones or exenatide. Discussion of other anti-diabetic treatment strategies is not included.Results: T2DM results from a combination of insulin resistance and beta-cell dysfunction. The combination of a thiazolidinedione and an incretin mimetic offers a combination of characteristics (e.g., glycemic control, reduced insulin resistance, decreased weight, potential cardiovascular benefits, beta-cell preservation) that addresses many of the pathophysiologic underpinnings of T2DM. A recent small placebo-controlled study assessed the effects of exenatide used with a thiazolidinedione (TZD; pioglitazone or rosiglitazone) with or without metformin. Exenatide demonstrated a greater incidence of glycosylated hemoglobin (HbA1c) < 7%; greater reductions in fasting blood glucose, postprandial plasma glucose and body weight; and improved beta-cell function versus the TZD/placebo group. However, exenatide was associated with a high dropout rate, and the 16-week duration of treatment in this study precluded evaluation of the long-term effects of the exenatide/pioglitazone combination. Furthermore, exenatide/pioglitazone has not been compared with any other anti-diabetic combination in a head-to-head clinical study.Conclusions: Dual effects on insulin sensitivity (TZD) and insulin secretion (exenatide) make the TZD/exenatide combination a rational treatment option for patients who do not attain glycemic control with a single agent. Studies undertaken to evaluate the effects on cardiovascular outcomes and the potential for prevention of T2DM with impaired glucose tolerance may reveal additional advantages of this combination approach." @default.
- W2125848783 created "2016-06-24" @default.
- W2125848783 creator A5007452437 @default.
- W2125848783 date "2008-10-02" @default.
- W2125848783 modified "2023-10-16" @default.
- W2125848783 title "Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide" @default.
- W2125848783 cites W1555860740 @default.
- W2125848783 cites W1585447752 @default.
- W2125848783 cites W1595574639 @default.
- W2125848783 cites W1964716328 @default.
- W2125848783 cites W1968973887 @default.
- W2125848783 cites W1970016552 @default.
- W2125848783 cites W1970185541 @default.
- W2125848783 cites W1972136146 @default.
- W2125848783 cites W1973245422 @default.
- W2125848783 cites W1973901069 @default.
- W2125848783 cites W1975756049 @default.
- W2125848783 cites W1982990554 @default.
- W2125848783 cites W1983000201 @default.
- W2125848783 cites W1984740259 @default.
- W2125848783 cites W1986085856 @default.
- W2125848783 cites W1987941106 @default.
- W2125848783 cites W1990724339 @default.
- W2125848783 cites W1991258108 @default.
- W2125848783 cites W1993162167 @default.
- W2125848783 cites W1997030483 @default.
- W2125848783 cites W1997416444 @default.
- W2125848783 cites W2003380560 @default.
- W2125848783 cites W2004977380 @default.
- W2125848783 cites W2006853439 @default.
- W2125848783 cites W2008497553 @default.
- W2125848783 cites W2008674682 @default.
- W2125848783 cites W2010788192 @default.
- W2125848783 cites W2011499650 @default.
- W2125848783 cites W2014113220 @default.
- W2125848783 cites W2016746678 @default.
- W2125848783 cites W2016901721 @default.
- W2125848783 cites W2024874163 @default.
- W2125848783 cites W2028038659 @default.
- W2125848783 cites W2028272916 @default.
- W2125848783 cites W2031891480 @default.
- W2125848783 cites W2033213907 @default.
- W2125848783 cites W2037447341 @default.
- W2125848783 cites W2038961236 @default.
- W2125848783 cites W2039296612 @default.
- W2125848783 cites W2042845313 @default.
- W2125848783 cites W2044034911 @default.
- W2125848783 cites W2048998821 @default.
- W2125848783 cites W2050826565 @default.
- W2125848783 cites W2051167429 @default.
- W2125848783 cites W2063400466 @default.
- W2125848783 cites W2064617441 @default.
- W2125848783 cites W2069150029 @default.
- W2125848783 cites W2070710390 @default.
- W2125848783 cites W2072997067 @default.
- W2125848783 cites W2075183867 @default.
- W2125848783 cites W2076310317 @default.
- W2125848783 cites W2077149049 @default.
- W2125848783 cites W2082432305 @default.
- W2125848783 cites W2087707716 @default.
- W2125848783 cites W2092700428 @default.
- W2125848783 cites W2093738306 @default.
- W2125848783 cites W2097135163 @default.
- W2125848783 cites W2098933436 @default.
- W2125848783 cites W2100629874 @default.
- W2125848783 cites W2101613382 @default.
- W2125848783 cites W2102675827 @default.
- W2125848783 cites W2103156933 @default.
- W2125848783 cites W2105407506 @default.
- W2125848783 cites W2107767863 @default.
- W2125848783 cites W2108771199 @default.
- W2125848783 cites W2110725041 @default.
- W2125848783 cites W2111480060 @default.
- W2125848783 cites W2113130966 @default.
- W2125848783 cites W2114781769 @default.
- W2125848783 cites W2123744385 @default.
- W2125848783 cites W2123946565 @default.
- W2125848783 cites W2127125241 @default.
- W2125848783 cites W2129377335 @default.
- W2125848783 cites W2129512027 @default.
- W2125848783 cites W2129730863 @default.
- W2125848783 cites W2131215476 @default.
- W2125848783 cites W2132594773 @default.
- W2125848783 cites W2135729475 @default.
- W2125848783 cites W2136491667 @default.
- W2125848783 cites W2140791028 @default.
- W2125848783 cites W2145335273 @default.
- W2125848783 cites W2154595662 @default.
- W2125848783 cites W2154909966 @default.
- W2125848783 cites W2158822657 @default.
- W2125848783 cites W2159083249 @default.
- W2125848783 cites W2159205789 @default.
- W2125848783 cites W2159969745 @default.
- W2125848783 cites W2162313978 @default.
- W2125848783 cites W2162934281 @default.
- W2125848783 cites W2164367541 @default.
- W2125848783 cites W2164416879 @default.
- W2125848783 cites W2166226788 @default.